Publication Date:
2012
abstract:
Proteins carry out their functions through interactions with different partners. Dynamic conformational switching among different structural sub-states favors the adaptation to the shapes of the different partners. Such conformational changes can be determined by diverse biochemical factors, such as ligand-binding. Atomic level investigations of the mechanisms that underlie functional dynamics may provide new opportunities for the discovery of leads that target disease-related proteins. In this review, we report our views and approaches on the development of novel and accurate physical-chemistry-based models for the characterization of the salient aspects of the ligand-regulated dynamics of Hsp90, and on the exploitation of such new knowledge for the rational discovery of inhibitors of the chaperone. © 2012 by the authors; licensee MDPI, Basel, Switzerland.
Iris type:
1.1 Articolo in rivista
Keywords:
Allostery; Binding; Drug design; Dynamic drug discovery; Hsp90; Inhibitors; Molecular dynamics; Simulations
List of contributors:
Moroni, E; Morra, G; Colombo, G
Published in: